How to Reduce Mortality in Hemodialysis Patients Still a Puzzle

Optical indicators of baseline blood status in dialysis patients

“…1 While provision of the proper dose (duration and frequency) of dialysis therapy is recognized as an essential component to improving survival, most indicators of dialysis dose focus on short-term changes in blood analytes (eg., urea) which, while convenient to measure, are poor indicators of long-term outcome. 2,3 Determination of adequate dialysis dose is further complicated by the influence of patient-specific factors on the dialysis dose, such as diet, level of activity, and physiologic factors.…”

Optical indicators of baseline blood status in dialysis patients

“…1 While provision of the proper dose (duration and frequency) of dialysis therapy is recognized as an essential component to improving survival, most indicators of dialysis dose focus on short-term changes in blood analytes (eg., urea) which, while convenient to measure, are poor indicators of long-term outcome. 2,3 Determination of adequate dialysis dose is further complicated by the influence of patient-specific factors on the dialysis dose, such as diet, level of activity, and physiologic factors.…”

Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients

“…Further studies suggest that non‐traditional risk factors for CVD in these subjects such as inflammation, anaemia or high calcium × phosphorus ion product may contribute to the accelerated atherosclerosis [24–26]. However, trials have failed to show differences in treatment options that would reduce mortality rates for end stage renal disease (ESRD) patients on MHD [27,28].…”

Optical indicators of baseline blood status in dialysis patients

“…1 While provision of the proper dose (duration and frequency) of dialysis therapy is recognized as an essential component to improving survival, most indicators of dialysis dose focus on short-term changes in blood analytes (eg., urea) which, while convenient to measure, are poor indicators of long-term outcome. 2,3 Determination of adequate dialysis dose is further complicated by the influence of patient-specific factors on the dialysis dose, such as diet, level of activity, and physiologic factors.…”

Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients

“…Further studies suggest that non‐traditional risk factors for CVD in these subjects such as inflammation, anaemia or high calcium × phosphorus ion product may contribute to the accelerated atherosclerosis [24–26]. However, trials have failed to show differences in treatment options that would reduce mortality rates for end stage renal disease (ESRD) patients on MHD [27,28].…”

Optical indicators of baseline blood status in dialysis patients

“…1 While provision of the proper dose (duration and frequency) of dialysis therapy is recognized as an essential component to improving survival, most indicators of dialysis dose focus on short-term changes in blood analytes (eg., urea) which, while convenient to measure, are poor indicators of long-term outcome. 2,3 Determination of adequate dialysis dose is further complicated by the influence of patient-specific factors on the dialysis dose, such as diet, level of activity, and physiologic factors.…”

Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients

“…Further studies suggest that non‐traditional risk factors for CVD in these subjects such as inflammation, anaemia or high calcium × phosphorus ion product may contribute to the accelerated atherosclerosis [24–26]. However, trials have failed to show differences in treatment options that would reduce mortality rates for end stage renal disease (ESRD) patients on MHD [27,28].…”